This company has not had a history of gouging shareholders... the ER for their other funds are quite reasonable for the amount of research and strong returns the company delivers... for a fund that will provide global research and asset allocation and invest in foreign and domestic stock, bond and alternate asset classes on both long and short sides, I think this is a fair ER... its theoretically the most active management you can get, and this company has proven they deliver...

The thing that remains to be seen is how their research will fare on the global side... we have not seen the results of that as all of their research has been domestic and when they have ventured into foreign markets its been via ETFs... but if any companies global fund is worth a look and worth following to see how it does it would seem to be this one... check out GLBIX since inception versus any of the global funds and its pretty impressive

Ajw